Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 24Thoracic 3Gynecologic 2Genitourinary 2Breast 2Head & Neck 1

Conditions

Breast Neoplasms 543Triple Negative Breast Neoplasms 97Ovarian Neoplasms 58Colorectal Neoplasms 50Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 44Neoplasms 38Lung Neoplasms 33Melanoma 29Endometrial Neoplasms 29Neoplasm Metastasis 28Stomach Neoplasms 26Pancreatic Neoplasms 26Uterine Cervical Neoplasms 25Squamous Cell Carcinoma of Head and Neck 22Colonic Neoplasms 20Head and Neck Neoplasms 18Carcinoma, Renal Cell 18Esophageal Neoplasms 16Sarcoma 14Advanced Breast Cancer 14Small Cell Lung Carcinoma 13Urinary Bladder Neoplasms 12Liver Neoplasms 11Carcinoma, Transitional Cell 11Kidney Neoplasms 10Carcinoma, Intraductal, Noninfiltrating 10Brain Neoplasms 10Lymphedema 9Anatomic Stage I Breast Cancer AJCC v8 9

Interventions

zanidatamab 1trastuzumab deruxtecan 1Trastuzumab 1Nivolumab 1Capecitabine 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Adenocarcinoma Of Esophagus × Breast × 30 days × Clear all
NCT06324357 2026-05-26

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Boehringer Ingelheim

Phase 1/2 Recruiting
768 enrolled
BreastGastrointestinal

Adenocarcinoma Of Esophagus, Breast Neoplasms, Colorectal Neoplasms

NCT07334119 2026-05-20

Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

Myeloid Therapeutics

Phase 1 Recruiting
60 enrolled
BreastGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Ovarian Epithelial, Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡